Episode Details
Back to Episodes
Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing
Published 12 years, 1 month ago
Description
Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.
Mentioned in this episode:
Researchers are studying the link between sense of smell and brain health. People with and without Parkinson's can help by taking a scratch-and-sniff test. It’s free, mailed to your home and takes just 15 minutes to complete. mysmelltest.org/getstarted